PD-1 Antibody for Reactive EBV After BMT

Status Not yet recruiting

Clinical Trial Summary

PD-1 antibody for reactivation of EBV after transplantation in patients with CAEBV/EBV-HLH

Clinical Trial Description

Transplantaion is recongnized as a cure for CAEBV and EBV associated HLH，however, many patients undergo the reactivation of EBV after transpaltion, patiens may at high risk for recurrence of the disease. PD-1 is a promising therapy to solve this problem. The present study was a one-arm clinical study, the main subject is to evaluate the effect of PD-1 antibody on the clearance of EBV ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04690036
Study type	Interventional
Source	Beijing Friendship Hospital
Contact	Zhao Wang
Phone	86-010-63139862
Email	wangzhao@ccmu.edu.cn
Status	Not yet recruiting
Phase	Early Phase 1
Start date	July 1, 2021
Completion date	January 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05047068` - OCS Heart Perfusion Post-Approval Registry
Completed	`NCT03455062` - Fertility Study of Women Who Received Organ Transplantation	N/A
Terminated	`NCT05033548` - Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Recruiting	`NCT04182607` - Donor Outcomes Following Hand-Assisted And Robotic Living Donor Nephrectomy: A Retrospective Review
Completed	`NCT01022905` - Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients	Phase 4
Completed	`NCT00436384` - Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients	Phase 4
Active, not recruiting	`NCT03691220` - Improving Medication Adherence in Adolescents Who Had a Liver Transplant	N/A
Completed	`NCT00571818` - The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients	N/A
Terminated	`NCT00884039` - Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients	N/A
Completed	`NCT00677677` - Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients	Phase 3
Completed	`NCT03860818` - Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention	N/A
Recruiting	`NCT04626167` - Concomitant Renal and Urinary Bladder Allograft Transplantation	Early Phase 1
Completed	`NCT01389804` - Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care	N/A
Recruiting	`NCT04390724` - Optimizing Y90 Therapy for Radiation Lobectomy
Active, not recruiting	`NCT00152802` - Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine	Phase 4
Not yet recruiting	`NCT05951231` - Liver Transplantation After ex Vivo Liver Perfusion	N/A
Completed	`NCT00242099` - Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant	Phase 4
Recruiting	`NCT05717842` - Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
Recruiting	`NCT05655546` - ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals	N/A
Recruiting	`NCT06161454` - Xofluza-Wearables Feasibility-Study	Phase 4